BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22354705)

  • 1. Cannabinoids and muscular pain. Effectiveness of the local administration in rat.
    Sánchez Robles EM; Bagües Arias A; Martín Fontelles MI
    Eur J Pain; 2012 Sep; 16(8):1116-27. PubMed ID: 22354705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain.
    Bagüés A; Martín MI; Sánchez-Robles EM
    Eur J Pharmacol; 2014 Dec; 745():69-75. PubMed ID: 25446925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.
    Ahmed MM; Rajpal S; Sweeney C; Gerovac TA; Allcock B; McChesney S; Patel AU; Tilghman JI; Miranpuri GS; Resnick DK
    Spine J; 2010 Dec; 10(12):1049-54. PubMed ID: 20920894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the CB
    Khan MI; Sobocińska AA; Brodaczewska KK; Zielniok K; Gajewska M; Kieda C; Czarnecka AM; Szczylik C
    BMC Cancer; 2018 May; 18(1):583. PubMed ID: 29792186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone.
    Elmas P; Ulugol A
    J Neural Transm (Vienna); 2013 Nov; 120(11):1533-8. PubMed ID: 23784345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
    Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
    Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
    Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
    Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of neuropeptide FF system on CB₁ and CB₂ receptors mediated antinociception in mice.
    Fang Q; Han ZL; Li N; Wang ZL; He N; Wang R
    Neuropharmacology; 2012 Feb; 62(2):855-64. PubMed ID: 21945715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CB2 cannabinoid receptor-mediated peripheral antinociception.
    Malan PT; Ibrahim MM; Deng H; Liu Q; Mata HP; Vanderah T; Porreca F; Makriyannis A
    Pain; 2001 Sep; 93(3):239-245. PubMed ID: 11514083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical cannabinoid antinociception: synergy with spinal sites.
    Dogrul A; Gul H; Akar A; Yildiz O; Bilgin F; Guzeldemir E
    Pain; 2003 Sep; 105(1-2):11-6. PubMed ID: 14499415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive effect of the cannabinoid agonist, WIN 55,212-2, in the orofacial and temporomandibular formalin tests.
    Burgos E; Pascual D; Martín MI; Goicoechea C
    Eur J Pain; 2010 Jan; 14(1):40-8. PubMed ID: 19318283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid system of the lateral septum in the modulation of anxiety-like behaviors in rats.
    Hajizadeh Moghaddam A; Bigdellu R; Fatemi Tabatabaei SR; Roohbakhsh A
    Arch Iran Med; 2013 Dec; 16(12):711-6. PubMed ID: 24329144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral and central sites of action for the non-selective cannabinoid agonist WIN 55,212-2 in a rat model of post-operative pain.
    Zhu CZ; Mikusa JP; Fan Y; Hollingsworth PR; Pai M; Chandran P; Daza AV; Yao BB; Dart MJ; Meyer MD; Decker MW; Hsieh GC; Honore P
    Br J Pharmacol; 2009 Jun; 157(4):645-55. PubMed ID: 19371344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bidirectional roles of the brain 2-arachidonoyl-sn-glycerol in the centrally administered vasopressin-induced adrenomedullary outflow in rats.
    Shimizu T; Yokotani K
    Eur J Pharmacol; 2008 Mar; 582(1-3):62-9. PubMed ID: 18234185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic effects of cannabinoid receptor agonist WIN55,212-2 in the nucleus cuneiformis in animal models of acute and inflammatory pain in rats.
    Ebrahimzadeh M; Haghparast A
    Brain Res; 2011 Oct; 1420():19-28. PubMed ID: 21911208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test.
    Cagni P; Barros M
    Behav Brain Res; 2013 Mar; 240():91-4. PubMed ID: 23183218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity of adolescent spontaneously hypertensive rats, an animal model of attention deficit hyperactivity disorder, to the locomotor stimulation induced by the cannabinoid receptor agonist WIN 55,212-2.
    Pandolfo P; Pamplona FA; Prediger RD; Takahashi RN
    Eur J Pharmacol; 2007 Jun; 563(1-3):141-8. PubMed ID: 17374533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol.
    McMahon LR
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antinociceptive effect of cannabinoid agonist WIN 55,212-2 in rats with a spinal cord injury.
    Hama A; Sagen J
    Exp Neurol; 2007 Mar; 204(1):454-7. PubMed ID: 17045264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test.
    Yoon MH; Choi JI
    Anesthesiology; 2003 Sep; 99(3):701-7. PubMed ID: 12960556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.